Cho Soo Yeon, An Tae Hun, Shim Soo Bin, Lee Myungjin, Jung Ki Tae
Department of Anesthesiology and Pain Medicine, Chosun University Hospital, Gwangju, Korea.
Department of Anesthesiology and Pain Medicine, School of Medicine, Chosun University, Gwangju, Korea.
Anesth Pain Med (Seoul). 2023 Apr;18(2):139-147. doi: 10.17085/apm.22246. Epub 2023 Apr 28.
Perioperative hyperglycemia can occur in surgical patients and may increase postoperative morbidity and mortality, especially in patients with diabetes. Therefore, we conducted the present study to evaluate whether the administration of 6% hydroxyethyl starch (HES)-130/0.4 increases blood glucose levels in patients with diabetes.
Forty patients undergoing lower limb surgery under spinal anesthesia were randomly allocated into two groups according to the fluids administered 20 min before spinal anesthesia (Group L, lactated Ringer's solution; Group H, 6% HES-130/0.4). Patient characteristics, intraoperative variables, blood glucose levels, mean blood pressure (MBP), and heart rate (HR) were recorded at five time-points (0, 20, 60, 120, and 240 min).
A total of 39 patients were analyzed (Group L, n = 20; Group H, n = 19). The amount of intraoperative fluid was significantly higher in Group L than in Group H (718.2 ml vs. 530.0 ml, P = 0.010). There were no significant differences in the changes in blood glucose levels, HR, or MBP between the two groups (P = 0.737, P = 0.896, and P = 0.141, respectively). Serial changes in mean blood glucose levels from baseline also showed no significant differences between the groups (P = 0.764).
There were no significant changes in blood glucose levels when lactated Ringer's solution or 6% HES-130 was used. When compared to the lactated Ringer's solution, no evidence that 6% HES-130/0.4 produces hyperglycemia in diabetic patients could be found. Further evaluation of larger populations is needed.
围手术期高血糖可发生于外科手术患者,且可能增加术后发病率和死亡率,尤其是糖尿病患者。因此,我们开展本研究以评估给予6%羟乙基淀粉(HES)-130/0.4是否会使糖尿病患者血糖水平升高。
40例接受脊髓麻醉下行下肢手术的患者,根据脊髓麻醉前20分钟给予的液体随机分为两组(L组,乳酸林格氏液;H组,6% HES-130/0.4)。在五个时间点(0、20、60、120和240分钟)记录患者特征、术中变量、血糖水平、平均血压(MBP)和心率(HR)。
共分析39例患者(L组,n = 20;H组,n = 19)。L组术中液体量显著高于H组(718.2 ml对530.0 ml,P = 0.010)。两组血糖水平、HR或MBP的变化无显著差异(分别为P = 0.737、P = 0.896和P = 0.141)。两组平均血糖水平相对于基线的系列变化也无显著差异(P = 0.764)。
使用乳酸林格氏液或6% HES-130时血糖水平无显著变化。与乳酸林格氏液相比,未发现有证据表明6% HES-130/0.4会使糖尿病患者发生高血糖。需要对更大样本量进行进一步评估。